Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Bioassay of prostate-specific antigen (PSA) using microcantilevers
Guanghua Wu
, Ram H. Datar
, Karolyn M. Hansen
, Thomas Thundat
,
Richard J. Cote
, Arun Majumdar
Department of Pathology & Immunology
Siteman Cancer Center
School of Medicine
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
DBBS - Immunology
DBBS - Cancer Biology
Research output
:
Contribution to journal
›
Article
›
peer-review
994
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Bioassay of prostate-specific antigen (PSA) using microcantilevers'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Clinically Significant
100%
Prostate-specific Antigen
100%
Microcantilever
100%
Biomolecular Binding
100%
Prostate Cancer
50%
Multiple Proteins
50%
Protein Drug
50%
Diagnostic Techniques
50%
Complex Disease
50%
Protein-DNA Interaction
50%
Human Serum Albumin
50%
Quantitative Detection
50%
Free Energy Change
50%
High-throughput
50%
Drug Discovery
50%
Disease-related Proteins
50%
DNA Hybridization
50%
Label-free Method
50%
Cantilever
50%
Label-free Analysis
50%
Micro-cantilever Beam
50%
Common Platform
50%
Cantilever Motion
50%
Protein-protein Binding
50%
Human Plasminogen
50%
Nanomechanics
50%
Cantilever Array
50%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Specific Antigen
100%
Diseases
100%
Malignant Neoplasm
50%
Prostate Cancer
50%
DNA Binding Protein
50%
Human Serum Albumin
50%
Chlordiazepoxide
50%
Protein Characterization
50%
Drug Discovery
50%
Deoxyribonucleoprotein
50%
Molecular Mechanic
50%
Plasminogen
50%
Biochemistry, Genetics and Molecular Biology
Prostate-Specific Antigen
100%
Binding Protein
50%
Motion
50%
Protein-DNA Interaction
50%
Human Serum Albumin
50%
Protein Characterization
50%
DNA Hybridization
50%
Molecular Mechanic
50%
Chlordiazepoxide
50%
Drug Development
50%